This Cancellation was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on December 07, 2020 and assigned serial number 92075897 by the TTAB.

Defendant:
Hauora Med S.r.l. represented by CHRISTOPHER B LAY of IPHORGAN LTD.
Trademark Information: NEXRUTINE – US Trademark Serial Number 76048316
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Hi-Tech Pharmaceuticals, Inc. represented by GREGORY L HILLYER of HILLYER LEGAL PLLC.
Trademark Information: NEXRUTINE – US Trademark Serial Number 90354136
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
December 07, 2020 – FILED AND FEE
December 08, 2020 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
December 08, 2020 – INSTITUTED
January 13, 2021 – D CHANGE OF CORRESP ADDRESS
January 13, 2021 – D MOT TO JOIN/SUBSTITUTE PARTY
January 13, 2021 – ANSWER
February 16, 2021 – TRIAL DATES REMAIN AS SET
March 16, 2021 – D MOT FOR EXT W/ CONSENT
March 16, 2021 – EXTENSION OF TIME GRANTED
September 24, 2021 – P MOT FOR SUMMARY JUDGMENT
October 04, 2021 – SUSP PEND DISP OF OUTSTNDNG MOT
October 04, 2021 – SUSP PEND DISP OF OUTSTNDNG MOT
October 04, 2021 – SUSP PEND DISP OF OUTSTNDNG MOT
October 04, 2021 – SUSP PEND DISP OF OUTSTNDNG MOT
July 06, 2022 – BD DECISION: CAN GRANTED
July 11, 2022 – COMMR ORDER CANCELLING REG
July 11, 2022 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.